The role of ATRX in glioma biology

Pravanya Nandakumar, Alireza Mansouri, Sunit Das

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.

Original languageEnglish (US)
Article number236
JournalFrontiers in Oncology
Volume7
Issue numberSEP
DOIs
StatePublished - Sep 29 2017

Fingerprint

Glioma
Epigenomics
Cell Biology
Carcinogenesis
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nandakumar, Pravanya ; Mansouri, Alireza ; Das, Sunit. / The role of ATRX in glioma biology. In: Frontiers in Oncology. 2017 ; Vol. 7, No. SEP.
@article{95f3a0cf4bde49a599349ad1ae299389,
title = "The role of ATRX in glioma biology",
abstract = "The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.",
author = "Pravanya Nandakumar and Alireza Mansouri and Sunit Das",
year = "2017",
month = "9",
day = "29",
doi = "10.3389/fonc.2017.00236",
language = "English (US)",
volume = "7",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

The role of ATRX in glioma biology. / Nandakumar, Pravanya; Mansouri, Alireza; Das, Sunit.

In: Frontiers in Oncology, Vol. 7, No. SEP, 236, 29.09.2017.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The role of ATRX in glioma biology

AU - Nandakumar, Pravanya

AU - Mansouri, Alireza

AU - Das, Sunit

PY - 2017/9/29

Y1 - 2017/9/29

N2 - The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.

AB - The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gliomas and their high-grade variants. The ATRX status is one of the critical markers that define the molecular classification of gliomas. In this review, we will first provide an overview of the role of ATRX in regular cell biology. Furthermore, the role of ATRX in tumorigenesis, specifically gliomas, is comprehensively elucidated. The possible correlation of ATRX status with other genetic/epigenetic modifications is also presented. We conclude by discussing some of the challenges associated with incorporating ATRX status assessment into routine clinical practice while also exploring opportunities for future diagnostics/therapeutics in gliomas based on ATRX status.

UR - http://www.scopus.com/inward/record.url?scp=85043788508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043788508&partnerID=8YFLogxK

U2 - 10.3389/fonc.2017.00236

DO - 10.3389/fonc.2017.00236

M3 - Review article

AN - SCOPUS:85043788508

VL - 7

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - SEP

M1 - 236

ER -